Volume | 176,072 |
|
|||||
News | - | ||||||
Day High | 1.4199 | Low High |
|||||
Day Low | 1.255 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Personalis Inc | PSNL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.26 | 1.255 | 1.4199 | 1.38 | 1.26 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,100 | 176,072 | $ 1.37 | $ 241,815 | - | 0.8906 - 2.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:32:27 | 1 | $ 1.40 | USD |
Personalis Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
69.7M | 50.50M | - | 73.48M | -108.3M | -2.14 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Personalis News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PSNL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.235 | 1.4199 | 1.18 | 1.24 | 260,397 | 0.155 | 12.55% |
1 Month | 1.50 | 1.54 | 1.18 | 1.34 | 229,688 | -0.11 | -7.33% |
3 Months | 1.54 | 1.80 | 1.12 | 1.44 | 339,527 | -0.15 | -9.74% |
6 Months | 0.98 | 2.38 | 0.8906 | 1.47 | 510,188 | 0.41 | 41.84% |
1 Year | 2.45 | 2.60 | 0.8906 | 1.60 | 370,541 | -1.06 | -43.27% |
3 Years | 22.79 | 28.47 | 0.8906 | 7.74 | 444,213 | -21.40 | -93.90% |
5 Years | 23.70 | 53.46 | 0.8906 | 14.75 | 492,364 | -22.31 | -94.14% |
Personalis Description
Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. |